In many cases it is safe, but certain antihypertensives-especially α-blockers-can amplify the blood-pressure-lowering effect of tadalafil. Your prescriber should review all current medications and may adjust doses or choose an alternative regimen.
No. Tadalafil’s absorption is not significantly affected by food, while dapoxetine is better tolerated when taken with a meal. Taking the tablet with food can reduce gastrointestinal side effects such as nausea.
Moderate alcohol consumption does not usually prevent the medication from working, but excessive drinking can increase dizziness, lower blood pressure, and diminish erectile response. Limiting alcohol intake around the time of sexual activity is advisable.
Tadalafil provides a therapeutic window of up to 36 hours, whereas dapoxetine’s effect peaks within 2-3 hours and diminishes after about 6 hours. The combined benefits are therefore aligned with the timing of a single dose taken 1-3 hours before intercourse.
Seek emergency medical care immediately. A prolonged erection (priapism) can cause permanent tissue damage if not treated promptly.
Yes, but you should keep the medication in its original packaging with a copy of the prescription (if required). Some countries have strict rules on importing prescription medicines, so it is prudent to check the destination’s regulations before travel.
The combined tablet delivers the same doses of each active ingredient, offering the convenience of a single pill. Pharmacologically, there is no difference in efficacy or safety compared with taking the two drugs individually, provided the dosing schedule is the same.
Typical tablet excipients may include lactose, magnesium stearate, microcrystalline cellulose, and colorants. If you have known sensitivities, review the product’s full ingredient list or ask your pharmacist.
Because the fixed-dose combination is not a separately licensed product, it is generally not listed on standard NHS formularies. Reimbursement depends on local prescribing policies and may require a private prescription.
Super Vidalista is a combined oral pill that contains two active ingredients: tadalafil (20 mg) and dapoxetine (60 mg). Tadalafil belongs to the phosphodiesterase-5 (PDE5) inhibitor class and is widely prescribed for erectile dysfunction (ED). Dapoxetine is a short-acting selective serotonin re-uptake inhibitor (SSRI) approved for the treatment of premature ejaculation (PE).
In the United Kingdom the individual components are each authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) for their respective indications. The fixed-dose combination marketed as Super Vidalista is not a separately licensed product; it is therefore considered an off-label use of the two medicines together. The medication is supplied as a tablet (pill) in the single strength of 20 mg/60 mg.
Tadalafil blocks the enzyme PDE5, which normally breaks down cyclic guanosine monophosphate (cGMP) in the smooth muscle of the penis. By inhibiting PDE5, cGMP accumulates, leading to relaxation of the smooth muscle and increased blood flow during sexual stimulation. The effect typically begins within 30 minutes and can last up to 36 hours, providing a relatively long therapeutic window.
Dapoxetine increases serotonin levels in the central nervous system by inhibiting its re-uptake. The heightened serotonergic tone lengthens the latency to ejaculation, helping men who experience PE. Because dapoxetine is rapidly absorbed and eliminated (half-life ≈ 1.5 hours), it is taken only shortly before sexual activity.
Together, the two agents address two distinct aspects of male sexual function: the ability to achieve and maintain an erection (tadalafil) and the ability to delay ejaculation (dapoxetine).
Both indications are approved for the individual ingredients in the UK. The combined tablet is used off-label to treat men who experience both ED and PE simultaneously.
The fixed-dose combination of tadalafil and dapoxetine has not undergone formal regulatory evaluation as a single product. However, clinical practice guidelines acknowledge that men with co-existing ED and PE may benefit from using a PDE5 inhibitor together with an SSRI such as dapoxetine. When the two agents are prescribed together, the same dosing intervals and safety considerations that apply to each drug singly should be observed.
Disclaimer: Off-label use must be supervised by a qualified healthcare professional who can assess individual risks and monitor response.
If any of the above conditions apply, discuss alternatives with a healthcare professional.
These effects are generally mild, self-limiting, and do not require medical intervention unless they persist.
General Advice: Patients should disclose all prescription medicines, over-the-counter products, herbal supplements, and dietary habits to their prescriber before starting Super Vidalista.
Signs of overdose may include severe headache, dizziness, chest pain, or prolonged erection. If any of these occur, seek emergency medical care. There is no specific antidote; treatment is supportive and may involve intravenous fluids, antihypertensives, or consultation with a toxicology service.
Super Vidalista can be stopped abruptly without tapering, as neither component causes physiological dependence. However, patients who have been using the medication regularly for ED may experience a return of symptoms. Discuss any concerns with a prescriber.
Routine laboratory monitoring is not required for most patients, but liver and kidney function tests may be ordered if underlying impairment is suspected.
This article provides educational information about Super Vidalista and is not a substitute for professional medical advice. Treatment decisions, including the use of unapproved combinations, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes only and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
